Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 11 December 2025

EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

European equities shook off an early wobble on Thursday, with most major EU indices closing solidly in the green as investors rotated into economically sensitive sectors and financials – even as technology stocks struggled under renewed AI‑bubble fears. The EU stock market today (11 December 2025) was shaped by three big forces: last night’s U.S. Federal Reserve rate cut, a cautious but supportive Swiss National Bank (SNB) decision, and a wave of stock‑specific news from Schneider Electric to Naturgy and Delivery Hero. Reuters+3Financial Times+3Reuters+3 How EU stock markets performed today By the closing bell on 11 December 2025: Intraday, the tone
11 December 2025
·····
Canada Stock Market Today: TSX Near Record High as Mining Stocks Climb, Tech and Energy Lag – December 11, 2025

Canada Stock Market Today: TSX Near Record High as Mining Stocks Climb, Tech and Energy Lag – December 11, 2025

Canada’s stock market continued its record‑setting run on Thursday, with the S&P/TSX Composite Index trading just above the 31,500 mark as investors weighed surging metal prices, a fresh trade surplus, and this week’s back‑to‑back interest‑rate decisions from the Bank of Canada and the U.S. Federal Reserve. TradingView+1 By late morning in Toronto, the S&P/TSX was up about 0.3% around 31,546, a new intraday high, after briefly opening in the red. TradingView+1 Gains in gold and base‑metal miners offset a sharp pullback in technology shares and another weak session for energy stocks, leaving the Canada stock market today looking more like a sector‑rotation story than a broad rally. TSX
11 December 2025
····
UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group Incorporated (NYSE: UNH) has been at the center of one of 2025’s biggest blue‑chip storylines: a brutal share-price collapse, a messy reset in Medicare Advantage, a Department of Justice (DOJ) probe, credit‑rating downgrades, and now a tentative turn toward recovery. Since November 21, 2025, a fresh wave of news, forecasts, and opinion pieces has reshaped how investors view UNH stock. Below is a structured, Google‑News‑friendly rundown of what’s happened from November 21, 2025 through today (December 11, 2025), what Wall Street expects for 2026, and what risks still hang over the story. UNH Stock Snapshot as of December
11 December 2025
·····
Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

NEW YORK – December 11, 2025 – Shares of Immunovant, Inc. (NASDAQ: IMVT) were sharply in focus on Thursday after the clinical‑stage immunology company announced a $550 million common stock financing designed to fund development and a potential commercial launch of its lead FcRn inhibitor, IMVT‑1402, in Graves’ disease.Immunovant, Inc.+1 By late afternoon, Immunovant stock was trading around $25.75, up roughly 9% on the day, with an intraday range between $22.03 and $25.87, giving the company a market value of about $4 billion.Stock Titan That upbeat finish came despite an initial sell‑off; one early report noted shares dropped around 7%
11 December 2025
·····
AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Inc. (NYSE: ABBV) has quietly turned into one of 2025’s standout large‑cap pharma stories. Shares are up roughly a mid‑20% percentage year‑to‑date, outpacing the broader market, powered by booming sales of Skyrizi and Rinvoq, a fresh dividend hike, and a string of oncology milestones — capped by an HSBC upgrade that just put AbbVie on the firm’s “preferred buys” list for 2026. Barchart.com+224/7 Wall St.+2 At the same time, the stock is still trading below its early‑October high, and investors are weighing Humira’s ongoing decline, softness in aesthetics, and regulatory risk against that growth story. Here’s a detailed look
11 December 2025
·····
Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Updated: December 11, 2025 Coeur Mining, Inc. (NYSE: CDE) has turned into one of 2025’s most dramatic comeback stories in precious metals. The U.S.-based gold‑and‑silver producer has delivered record cash flow, launched its largest exploration push in more than a decade, and unveiled a $7 billion all‑stock acquisition of New Gold Inc. that would create a new North American mining heavyweight. Coeur Mining+2Proactiveinvestors NA+2 At the same time, the stock has gone from forgotten mid‑cap to momentum darling. On December 11, 2025, CDE is trading around $16.84 per share, up roughly 5% intraday, with a session range between about $15.89
11 December 2025
·····
Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

As of December 11, 2025, Snowflake Inc. (NYSE: SNOW) sits right at the intersection of three powerful storylines: explosive AI demand, nervousness about profit margins, and mounting legal and regulatory risk. Since November 21, 2025, those threads have come together in a way that has materially reshaped the stock’s risk–reward profile. Snowflake shares currently trade around $218 per share, down roughly 7% from their $234.03 close on November 21, and about 22% below the three‑year high of $280.67 set on November 3. Investing.com+1 Even after the post‑earnings sell‑off, the stock remains more than 50% higher year‑to‑date, reflecting how central Snowflake
11 December 2025
····
Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde plc (NASDAQ: LIN) has had a turbulent end to 2025. After setting a fresh 52‑week low in late November, the world’s largest industrial gases company has attracted a wave of new analyst calls, insider buying from its CEO, and multiple debt and credit transactions that reshape its balance sheet and liquidity profile. This article pulls together the most important news, forecasts and analyses on Linde stock from November 21, 2025 through December 11, 2025, and sets them in the context of the company’s latest earnings and 2026 outlook. 1. Linde stock snapshot as of December 11, 2025 As of
11 December 2025
·····
Roku Stock Jumps on Fresh Analyst Upgrades: Is NASDAQ:ROKU Setting Up for a 2026 Breakout?

Roku Stock Jumps on Fresh Analyst Upgrades: Is NASDAQ:ROKU Setting Up for a 2026 Breakout?

Roku, Inc. (NASDAQ: ROKU) is back on center stage. On Thursday, December 11, 2025, the streaming platform’s stock is trading around the $109–110 mark, up strongly on the day and hovering near the top of its 52‑week range of roughly $52 to $117.Investing.com+1 A wave of new analyst calls, upbeat earnings trends, and a clearer path to profitable growth are now reshaping how Wall Street looks at Roku stock going into 2026. Roku Stock Today: Price, Momentum and Market Context Across major data providers, Roku’s share price sits in the low $100s, with today’s session pushing it close to the
11 December 2025
·····
Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio, Inc. (NASDAQ: BLTE) has turned into one of 2025’s most closely watched biotech stories. On the back of a pivotal Phase 3 win in Stargardt disease and a large equity raise, the small-cap ophthalmology specialist has seen its share price more than double this year and its market value climb into the multi‑billion‑dollar range.BioPharma Dive+1 As of the afternoon of December 11, 2025, Belite Bio stock is trading around $154 per share, up roughly 4–5% on the day and more than 130% year‑to‑date, giving the company a market capitalization of roughly $5–6 billion.Stock Titan+1 The rally has pushed
11 December 2025
·····
Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair Inc. (NYSE: W) is back in the market spotlight. As of Thursday, December 11, 2025, the online home-goods retailer’s stock is trading around $99–100 per share, up roughly 7% on the day from a prior close near $93.³Investing.com That move caps a roller-coaster year in which Wayfair has: Today’s story is a tug‑of‑war: hedge funds are buying, insiders have been selling, and analysts are sharply divided between rich upside and cooling enthusiasm. Below is a breakdown of the key news, forecasts, and analyses dated December 11, 2025, and how they fit into the bigger picture for Wayfair stock. Wayfair
11 December 2025
····
Qualcomm (QCOM) Stock News: AI Chip Breakthroughs, Ventana Deal and 2026 Outlook After November 21 Pivot

Qualcomm (QCOM) Stock News: AI Chip Breakthroughs, Ventana Deal and 2026 Outlook After November 21 Pivot

December 11, 2025 Qualcomm Incorporated (NASDAQ: QCOM) has moved from a choppy, headline‑driven November to a decisively AI‑centric story in early December, helped by new data‑center chips, a strategic acquisition in RISC‑V CPUs and fresh automotive AI announcements ahead of CES 2026. Since closing in the mid‑$160s on November 21, Qualcomm stock has climbed roughly 9% to about $179.55 in Thursday trading, outpacing many large semiconductor peers. Traders Union At the same time, Wall Street forecasts now cluster just above current levels, while technical analysts warn that QCOM looks overbought in the short term even as its long‑term AI and
11 December 2025
····
1 … 1,330 1,331 1,332 1,333 1,334 … 1,915

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
Sydney, Feb 7, 2026, 17:39 AEDT — Market closed. South32 Ltd shares (S32.AX) closed down 4.1% at A$4.41 on Friday, hit by the same risk-off wave that pushed Australian miners sharply lower. The stock traded between A$4.37 and A$4.51 and was down 19 cents from the prior close of A$4.60. (Intelligent Investor) With markets shut for the weekend, the move leaves South32 on the watchlist going into Monday’s open as investors reassess exposure to metals and mining names. The S&P/ASX 200 ended the week down 1.81%. (Morningstar) The benchmark fell 2% on Friday and almost A$70 billion was wiped off
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop